Keep your greedy hands off my genes!

The U.S. Supreme Court's invalidation of gene patents is a victory for basic principles of patent law, but public policy concerns remain unresolved

Ian Binnie, C.C., Q.C. and Vanessa Park-Thompson contributed an article to the Intellectual Property Journal.

"The face of the biotechnology industry changed dramatically this summer when the United States Supreme Court held in Association for Molecular Pathology v. Myriad Genetics Inc. that naturally occurring DNA segments1 are "products of nature" and therefore not patentable subject matter..."